Mesoblast (MESO) Share-based Compensation (QoQ) (2016 - 2023)
Mesoblast (MESO) Share-based Compensation (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 43.78% |
| Dec 31, 2022 | -302.00% |
| Sep 30, 2022 | -132.08% |
| Jun 30, 2022 | 157.76% |
| Mar 31, 2022 | -27.64% |
| Dec 31, 2021 | -37.55% |
| Sep 30, 2021 | -104.69% |
| Jun 30, 2021 | 1,236.14% |
| Mar 31, 2021 | -115.19% |
| Dec 31, 2020 | 372.53% |
| Sep 30, 2020 | -140.51% |
| Jun 30, 2020 | 679.28% |
| Mar 31, 2020 | -26.60% |
| Dec 31, 2019 | -104.35% |
| Sep 30, 2019 | -110.60% |
| Jun 30, 2019 | 736.86% |
| Mar 31, 2019 | 1.41% |
| Dec 31, 2018 | -47.68% |
| Sep 30, 2018 | -107.12% |
| Jun 30, 2018 | 1,011.75% |